(Q43968777)

English

Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition model.

scientific article published on 6 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

object named as

Léa Payen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mylène Honorat

6

object named as

Mylène Honorat

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Attilio Di Pietro

4

object named as

Attilio Di Pietro

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ahcène Boumendjel

7

object named as

Ahcène Boumendjel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alexandre Sostelly

1

object named as

Alexandre Sostelly

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

10

object named as

Michel Tod

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Jérôme Guitton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Annabelle Gèze

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gilles Freyer

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

6 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Fundamental and Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

161-169

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23384250%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

ABC transporters: unvalidated therapeutic targets in cancer and the CNS

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

A multidrug resistance transporter from human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Pharmacokinetic/pharmacodynamic modeling in drug development

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Modeling of tumor growth and anticancer effects of combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approach

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Learning versus confirming in clinical drug development

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Prediction discrepancies for the evaluation of nonlinear mixed-effects models.

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Evaluation of drugs in pediatrics using K-PD models: perspectives

1 reference

https://api.crossref.org/works/10.1111%2FFCP.12005

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43968777&oldid=2105131278"